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Somatic mutations arise and accumulate both during tumor genesis and progression.
However, the order in which mutations occur is an open question and the inference of
the temporal ordering at the gene level could potentially impact on patient treatment.
Thus, exploiting recent observations suggesting that the occurrence of mutations is
a non-memoryless process, we developed a computational approach to infer timed
oncogenetic directed acyclic graphs (TO-DAGs) from human tumor mutation data. Such
graphs represent the path and the waiting times of alterations during tumor evolution.
The probability of occurrence of each alteration in a path is the probability that the
alteration occurs when all alterations prior to it have occurred. The waiting time between
an alteration and the subsequent is modeled as a stochastic function of the conditional
probability of the event given the occurrence of the previous one. TO-DAG performances
have been evaluated both on synthetic data and on somatic non-silent mutations from
prostate cancer and melanoma patients and then compared with those of current
well-established approaches. TO-DAG shows high performance scores on synthetic data
and recognizes mutations in gatekeeper tumor suppressor genes as trigger for several
downstream mutational events in the human tumor data.
Keywords: mutagenetic graphs, timed graphs, cumulative cancer progression models, graph inference, prostate
cancer, melanoma
INTRODUCTION
The systematic analyses of human tumor genomes in the last decade revealed that cancer is due
to the combined effect of multiple driver mutations that accumulate and impair cell growth, cell
division, and cell destruction (Vogelstein et al., 1988; Stratton et al., 2009; Greaves and Maley,
2012; Garraway and Lander, 2013). Many oncogenes and tumor suppressor genes contributing to
tumorigenesis when activated or inactivated by acquired mutations have been identified, but the
order in which those deleterious mutations occur is poorly understood (Futreal et al., 2004; Michor
et al., 2004; Merlo et al., 2006; Gerstung et al., 2011; Sun et al., 2014). The sequence in which genetic
events occur is of fundamental interest to understand carcinogenesis, progression and ultimately to
guide therapeutics (Weinstein and Joe, 2008; Cheng et al., 2012; Turajlic et al., 2015). Specifically,
causal models of cancer progression based on timed graphs (dependency graphs representing timed
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processes/events connected by causal dependency relationships)
of genomic alterations can identify those mutations that
induce oncogenic addiction and may thus represent promising
therapeutic targets (Cheng et al., 2012).
The inference of timed graphs from cross- sectional data is a
challenging task. First, the order and the timing of the genetic
alterations can vary among patients (inter-patient heterogeneity)
and even among different tumor nodules from the same patient
(intra-patient heterogeneity; Vogelstein et al., 1988; Gerlinger
et al., 2012; Alizadeh et al., 2015; Beltran and Demichelis, 2015).
Second, the process of accumulating mutations is more complex
than what can be represented by a single path (Cheng et al.,
2012). Building on the pioneering linear model proposed by
Vogelstein et al. (1988), statistical methods considering branch
like trees and graphs have been proposed (Radmacher et al., 2001;
Beerenwinkel et al., 2005; Rahnenführer et al., 2005; Attolini
et al., 2010; Gerstung et al., 2011; Cheng et al., 2012; Longerich
et al., 2012). In a recent comprehensive review (Hainke et al.,
2012), the methods are grouped in: (i) oncogenetic tree models
(oncotrees; Desper et al., 2000; Beerenwinkel et al., 2005), (ii)
Bayesian graphical approaches (Radmacher et al., 2001; Gerstung
et al., 2009, 2011; Sakoparnig and Beerenwinkel, 2012), and
(iii) approaches based on clustering and evolutionary fitting
algorithms (Michor et al., 2004; Attolini et al., 2010; Cheng
et al., 2012). These methods generate graphs where the nodes
are genetic events (at the level of single genes or at the level
of gene pathways) and the directed arcs between nodes denote
a relationship between them. Figure S1 shows examples of
trees and graphs of different complexity obtained from the
co-occurrence tables (Figure S1A) with probabilistic tree-based
approaches (oncotree, Figure S1B), Bayesian inference (Figure
S1C), evolutionary algorithms (Figure S1D), and the probabilistic
graph modeling approach we developed (Figure S1E).
Briefly, the directed tree structures of oncotrees represent the
probabilities of accumulating further mutations along divergent
temporal sequences; each mutation can be represented only
once and can have multiple subsequent mutations (child
mutations) independently occurring; edges weights that are
transition probabilities from the parent mutation to the child
mutation. Distance-based oncotree approach involves generating
a phylogenetic tree over all events using a distance measure
between mutational events, where leaf nodes represent the set
of possible events (Desper et al., 2000). Further development of
cancer progression modeling by oncotree is known as mixture
tree model and includes multiple oncogenetic trees, each of
which can independently lead to cancer development. An
expectation maximization algorithm is then used to determine
the most likely tree mixture to fit the data (Beerenwinkel
et al., 2007a). One acknowledged restriction of tree-based
methods is that they preclude the possibility of converging
evolutionary paths that occur when multiple alterations result
in the same phenotypic effect. Furthermore, they impose a
strict ordering of events. Bayesian graphical methods on the
other hand can include converging evolutionary paths (Hjelm
et al., 2006; Gerstung et al., 2009). For instance Conjunctive
Bayesian Networks (CBNs) allow for multiple parental nodes
thereby modeling the synergistic effects of multiple events in
promoting subsequent mutations and describe the accumulation
of events that are constrained in the order of their occurrence
(Beerenwinkel et al., 2007b). The continuous time CBN (CT-
CBN; Gerstung et al., 2011) also includes an explicit timeline,
making quantitative predictions about the waiting time of
mutations and, consequently about the speed of the tumor
progression (Hainke et al., 2012). Detailed descriptions of the
three categories of methods are presented in Supplementary
Material.
The network-like representation of temporal order and the
relationships between genetic events provided by probabilistic
graph models and evolutionary fitting algorithms made their
use much more widespread than for oncotrees. However, the
theoretical model of the majority of graphs is based on pairwise
dependencies between genetic events; it assumes that mutations
are random events and that the accumulation process is a
memoryless stochastic process. Based on these assumptions,
current graph models are a simplistic generalization of the tree
models and allow only the specification of stochastic process
having the Markov property. Such memoryless property holds
when the conditional probability distribution of the process
next states depends only on the current state and not on the
sequence of states that preceded it. While current graph models
paved the way to a network-based modeling of the order and
timing of mutation events, new theoretical frameworks for
new computational models of probabilistic graphs need to be
developed to overcome these limitations.
Overcoming the Markov property assumption and the
limitation to “pairwise” dependencies between genetic events
might allow for causal dependency inference that better
resembles the real mutation accumulation process dynamics
of cancer formation. In this direction, we developed a novel
probabilistic graph model named Timed Oncogenetic Directed
Acyclic Graph (TO-DAG) aimed at estimating the order and
the waiting time of mutation events. Different than previously
proposed methods, TO-DAG doesn’t use Markov chains, but
defines a conditional probability measure on the mutational
patterns state space, for which the occurrence of a mutation
in a pattern is conditionally dependent on the occurrence
of all the preceding mutations. Such probabilities can be
estimated from the occurrence data of a set of genetic mutations
in a tumor/patient sample. Paths of mutations having non-
null statistically significant probabilities define the topological
structure of the cancer progression model. The waiting times
of the mutation events are estimated a posteriori as inversely
proportional to their conditional probability. In this way
TO-DAG inference method decouples the prediction of the
interdependencies among mutations from the estimate of the
exact time of occurrence of these mutations. Namely, the
conditional probability of a mutation is not defined as an explicit
function of the exact time of occurrence and determines only the
presence/absence of edges in a path ofmutations. This probability
is then interpreted as the rate of the occurrence of a mutation and
used to estimate the waiting time elapsing from the occurrence of
a mutation and its successor.
We first applied TO-DAG both on randomly generated
synthetic data and on structured non-random synthetic data
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(i.e., generated in a controlled manner) to test its performance
with respect to the number of genes, the number of samples
and the events frequencies and to assess to what extent the
output graphs reflect the input data structure. Next we turned to
genetic data that we recently generated from 74 human prostate
cancer samples that include point mutations, copy number
losses and gains, and rearrangements (Barbieri et al., 2012; Baca
et al., 2013). The models generated by TO-DAG have been
extensively compared with the trees and the graphs inferred by
most recent tools representative of the three classes, Oncogenetic
tree (Oncotree; Szabo and Boucher, 2002), CT-CBN (Gerstung
et al., 2011), Retracing the Evolutionary Steps in Cancer (RESIC;
Attolini et al., 2010).
The following sections of the manuscript present our novel
methodology, themutation networks inferred from synthetic and
real data and the discussion in the light of extensive comparison
with the networks inferred by the other methods.
METHODS: TIMED ONCOGENETIC
DIRECTED ACYCLIC GRAPH (TO-DAG)
TO-DAG is an inferential method that deduces from cross-
sectional data of genetic alterations in tumor patients the causal
dependencies and the waiting times among these genetic events.
From matrices with genetic events and patient samples as rows
and columns, respectively, TO-DAG generates a probabilistic
graph model whose nodes represent genetic events and oriented
edges between nodes indicate the presence and the direction of a
causal dependency between the nodes. A direct acyclic graph, i.e.,
a graph with no directed cycles, has been specifically chosen as
model of putative causal dependencies, as genetic alterations are
assumed to be irreversible events. Two parameters define an edge:
(i) its probability estimated from the frequency of occurrence of
the genetic events represented by the nodes and its conditional
probability, and (ii) the waiting time, i.e., the time elapsing from
the occurrence of a mutation to the occurrence of another one
that is conditionally dependent on it.
Six main steps define the inferential procedure of TO-DAG:
1. Calculation of the probability of genetic event mutation. The
probability of an event is calculated as the frequency of the
event in sample set.
2. Calculation of the conditional probability of each pair of
genetic events and construction of a complete directed graph
whose edge weights are proportional to the conditional
probabilities of the occurrence of the genetic events
represented by the target nodes, given that the genetic
event of the source nodes has occurred.
3. Elimination of edges with low probability.
4. Estimation of the waiting time between two events as
realization of an exponential process with rate proportional to
the conditional probability of the child event given the parent
event.
5. Update of the probability of each genetic event with the
probability of the event conditional to the occurrence of its
predecessors.
6. Graph path reduction to eliminate low-probability mutation
paths.
In the following we will describe in details the formalization of
the graph model generated by TO-DAG. Adopting the notation
from Szabo and Boucher (2002) to describe TO-DAG algorithm:
• let n be the number of genetic events
• let pi be the probability that the i-th genetic alteration occurs,
and i = 1, 2, . . . , n
• let pi∪j be the probability that the i-th or the j-th or both the
genetic alterations occur, and i, j = 1, 2, . . . , n
• let pi∩j be the probability that both the i-th and the j-th
alteration occur, and i, j = 1, 2, . . . , n provided that i 6= j
• Let pi|j be the probability that the i-th genetic event occurs
given that the j-th alteration has occurred. By the definition
of conditional probability pi|j is
pi|j =
pi∩j
pj
, i, j = 1, 2, . . . , n; i 6= j
The steps of the oncogenetic graph reconstruction algorithm are
defined as follow.
1. Estimate pi and pi∩j, i, j = 1, 2, . . . , n (i 6= j) from the data
using the above definitions.
2. Construct a complete DAG on vertices {v1, v2, . . . , vn}
representing the occurrence of the individual events
conditioned to their predecessor, with edge weights defined as
w
(
vi, vj
)
≡
pj|i
pi + pj
=
pi∩j
pi
(
pi + pj
)
for an edge from vertex vi to a vertex vj.
Accordingly to these definitions, an edge between two vertices
is drawn if the conditional probability of the target vertex given
the source vertex is not null. Weights are then assigned to the
edges vj → vi for which pi|j is large compared to the individual
probabilities pi and pj. The direction of an edge between node i
and node j is directed from i to j if w
(
vi, vj
)
> w(vj, vi) and from
j to i ifw
(
vi, vj
)
< w(vj, vi). Ifw
(
vi, vj
)
= w(vj, vi) an undirected
edge between i and j is drawn. In the present implementation of
the algorithm, no threshold is set on the tolerance within which to
compare the equality of the edge weights. Based on this definition
of edge weight and this rule for determining the edge orientation,
and edge between i and j is oriented from i to j if pi > pj, i.e., from
the most frequently mutated gene to the less frequently mutated
gene.
3. For a given confidence level γ, for all the edges in the graph
(i.e., edges with positive weight), define a confidence interval
for p ≡ pi + pj. Assuming that the sample mean of the
mutation probability p is normally distributed with sampling
variability given by p
(
1− p
)
/n, the confidence interval is
delimited by the roots of the polynomial
Fi|j
(
p
)
=
[
pi|j − p
]2
− zγ ≤ 0∀i, j = 1, 2, . . . , n
where pi|j is estimated from the data, and zγ is the quantile of
order γ or the standard Normal distribution.
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Let pmin and pmax be the roots of the polynomial pi|j(p) remove
from the graph the edges for which
pj|i < pi + pj +
(
pmax − pmin
)
This step implements a comparison between the nominator and
the denominator in the expression of w
(
vi, vj
)
to determine an
interval on pi+ pj beyond which we can consider the conditional
probability pj|i significantly greater than the sum of the single
probabilities.
Store the conditional probabilities pj|i satisfying this
condition.
4. For each event k in a pathway connecting k to its nk
predecessors (and for each pathway in the graph), update
the probability of the edge of the vertices
(
vk−1, vk
)
in the
following way
pk|k−1 ← pk|(k−1,k−2,...,k−nk) = pk∩(k−1)∩(k−2)···∩(k−nk)
(see Figure S10).
This step implements the replacement of the conditional
probability of event k given its direct predecessor k − 1 with
the probability of the event k conditional to all the predecessor
of event k. Remove from the graph those paths for which the
following condition is satisfied
pk∩(k−1)∩(k−2)···∩(k−nk) <
nk∑
h= 0
pk−h|k−(h+1)
5. For each edges vi → vj draw a realization △t from an
exponential distribution
8 ∼ λ exp (−λ△t) , λ ≡ pi|j
where △t is the waiting time, and the rate parameter λ is
just the conditional probability of the event j conditional to its
predecessor i, we stored at step 3. According to this definition,
the waiting time, i.e., the time elapsing from a mutation to a
subsequent one, is a random variable simulated by as a Markov
process. Thus, the waiting times are random and independent
each from the others, to reflect the impossibility to infer the exact
time of occurrence of a mutation from the observed data.
We assume that the Markovian property holds only for the
sequence of waiting times, and is not used to calculate the
event probabilities that define the edge distribution. Therefore,
Markovian processes do not define the topology of the causal
dependency graph. Figure 11S schematizes the assignment of
waiting time to the graph edges.
6. Waiting time based graph clustering to define three categories:
“fast” edges (△t < t1), “moderate” edges (t1 ≤ △t ≤ t2), and
“slow” edge (△t > t2), where t1 and t2 are the first and the
third quartiles of the waiting times distribution.
In the next section, we will present TO-DAG results obtained
on synthetic and real data and the comparison with other
methods. We refer the reader to Supplementary Material for
a detailed description of the three recent methods selected
for the comparison, Oncotree (Szabo and Boucher, 2002),
CT-CBN (Gerstung et al., 2011), and RESIC (Attolini et al.,
2010), representative of the three main classes of methods
for determining causal and temporal topologies of mutation
pathways.
RESULTS AND DISCUSSION: TO-DAG
PERFORMANCES AND COMPARATIVE
ANALYSIS WITH OTHER METHODS
Table 1 summarizes the characteristics of the considered
methods such as the type of output (tree or graph, timed network
or non-temporal model), the assumptions (e.g., Markovian
property of the mutation accumulation process), and technical
features such as the size of the input co-occurrence tables. Here
we report and compare the networks inferred with TO-DAG
and with Oncotree, CT-CBN, and RESIC considering two sets
of input data: (i) random uncorrelated data of different sizes
generated by varying the number of mutation events or/and
the number of samples, and (ii) synthetic data generated by
changing the mutation frequency of each genetic event (i.e., the
percentage of samples affected by a genetic aberration) or by
introducing disjoint sets of samples (i.e., sets of samples that do
no share any mutation event). The first set of experiments aims at
measuring the maximum size of the input co-occurrence table in
terms of number of events and number of mutational events, the
computational complexity, and the number of predicted edges as
a function of the input size. The latter is considered as a measure
of false positives. The second set of experiments tests the extent
to which different approaches are able to reflect the data structure
in the inferred graphical models.
Experiments on Random Binary Input
Matrices
The input to Oncotree, CT-CBN and TO-DAG is a matrix with
samples (S1, S2,..., S20) in rows and mutation events/genes (E1,
E2,..., E20) in columns, whereas for RESIC is the transposed
matrix (see Figure S2A). Random binary matrices with an equal
TABLE 1 | Output format, properties of inference models and
performances of Oncotree, CT-CBN, RESIC, and TO-DAG.
Oncotrees CT-CBN RESIC TO-DAG
Graph X X X
Timed network X X X
Topology/conditional
probability tables
X X
Non-memoryless X
PERFORMANCES
Max nr. of Mutation events ∼1K (*) 29 ∼1K ∼10K
Max nr. of Samples ∼0.1K (*) ∼100 ∼1K ∼10K
(*) Oncotree-package admits input matrices of larger dimensions however, the correct
ordering of estimated probabilities of the events and the computation of the joint
probabilities cannot be addressed with limited sample sizes and computational power.
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number of positive entries and null entries have been generated
through the Walker’s random sampling method by imposing a
mutation frequency of 50% for each genetic event (Breitung,
1989).
Oncotrees
One hundred oncotrees have been inferred from 100
co-occurrence matrices reporting a number of mutation
events/genes increasing from 10 to 1000 by 10 and a number of
samples equal to 50. The increment of the number of inferred
edges vs. the number of genes resulted to be linear (Figure
S2A). Similarly, 100 oncotrees have been inferred from 100 co-
occurrence matrices reporting a number of samples increasing
from 10 to 1000 by 10 and a number of genes equal to 50. The
number of edges vs. the number of samples resulted to be a
stiff negative exponential zeroing at approximately 200 genes
FIGURE 1 | Output graphs for synthetic data generated by step-wise increment of mutation rates. (A) Input matrices and corresponding (B) Oncotree tree
graphs, (C) graphs inferred by CT–CBN method, (D) graphs inferred by RESIC algorithm, and (E) graphs inferred by TO–DAG.
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(Figure S2D). The addition of samples to a binary matrix with
random uncorrelated entries makes the number of putative edges
converge to zero, i.e., the larger the number of observations on a
random binary process is, the smaller is the number of predicted
relationships among the instances of the process.
Figures S3A–D show the average edge weight and the
variances of the edge weights with respect to the number of genes
(Figures S3A,B) and the number of samples (Figures S3C,D).
CT-CBN
CT-CBN was tested on smaller co-occurrences tables as the
method can handle 30 samples maximum. Number of edges vs.
number of genes has been obtained on six co-occurrencematrices
with genes increasing from 5 to 30 by incremental step of 5 and
number of samples equal to 7. Similarly, for the number of arcs
vs. the number of samples, CT-CBN was applied to six matrices
with sample sizes increasing from 5 to 50 by incremental step of 5
and number of genes equal to 7. Although the modest size of the
input matrix, the inferential processing for a mutation frequency
of the 50% was computationally intractable with this method.
The increment of the number of arcs vs. the number of genes
is linear as with the oncotree method (Figure S2B), whereas the
decrement of the number of arcs associated to the increment
of the number of samples follows a hyperbolic behavior
(Figure S2E).
In CT-CBN the edge weights are calculated through
bootstrapping in multiple runs. However, given the small size
of the input matrix that this approach can process, estimates of
average edge weight and variance of the average edges weights
are not considered of statistical significance and thus are here
omitted.
RESIC
RESIC does not infer edges from uncorrelated random data
suggesting that false positives rates are likely low.
TO-DAG
TO-DAG infers a number of edges quadratically increasing with
the number of genes (see Figure S2C for 50 samples) and
following a sigmoidal function with respect to the number of
samples (see Figure S2F for 50 genes). Sample size increment
does not lead to lower number of putative edges as for oncotree
and CT-CBN methods, rather it stabilizes on a plateau. This
behavior is expected for models that maintain/track memory
of the past states. Furthermore, the level of the plateau of the
sigmoid obtained on random input can be interpreted as a
measure of false positive edges inferred by the method from
real data, provided that the random input matrix shows the
same mutation frequency of the real data. The existence of an
analytical relationship between the probability of a path in the
graph and the height of the sigmoid should be further assessed
and potentially used to determine a threshold to control for false
positives.
FIGURE 2 | Output graphs inferred from disjoint sample sets, i.e., set of samples that do not share any mutational event.
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Figures S3E–H show the behavior of the average edge weight
and the variances of the edge weights vs. number of genes
(Figures S3E,F) and vs. number of samples (Figures S3G,H).
Finally, we analyzed the rate parameter λ of the exponential
distribution as function of the number of genes and number of
samples. Figure S4A indicates an oscillatory behavior of λ when
the number of genes is less than 100 (and the number of samples
is fixed to 50), then followed by a more stable one when the
number of genes increases. Of note is the curve reported in Figure
S4B that indicates that λ decreases as the number of samples
increases till the null value. This suggests that if the number of
samples is significantly higher than the number of genes, the
distribution of the waiting times can be approximated without
loss of accuracy to a uniform distribution, and the waiting time
of mutation can be calculated as the inverse of λ.
We also explored two topological indices (assortativity and
transitivity) and the exponential rate of the waiting time
distribution against an increment of the mutation frequency to
evaluate and validate the performance of TO-DAG in inferring
the structure of interconnections among mutations. In this
experiment, mutation frequency changes have been realized by
randomly assigning different percentages of positive values to
the columns (samples) of the co-occurrence table. The results
are reported in Figure S5. Assortativity is here operationalized
as the correlation between the total degree (i.e., number of
edges) of two nodes. Transitivity (also known as clustering
coefficient) measures the probability that the adjacent vertices
of a vertex are connected. As the mutation frequency increases
we observed (i) a decrement of the assortativity as (Figure
S5A); (ii) a hump-shaped behavior of the median of the
distribution of local transitivity (Figure S5B); and (iii) a linear
increase of the parameter of the waiting time distribution.
Results (i) and (ii) indicate a weakening of the relationship
between nodes as the mutation frequency increases, whereas
result (iii) is a trivial consequence (by definition of “rate” of a
random Poisson process) of the augment of the frequency of
mutation.
While the strength of the relationship decreases as the
mutation frequency increases, we correspondingly observe a
moderate increment of the average edge weight and a moderate
decrease of the variance of distribution of edge weights (see
Figure S6).
FIGURE 3 | Output graphs obtained from intersecting sample sets, i.e., set of samples that share at least one mutation event.
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Experiments on Controlled Binary Input
Matrices
Synthetic data were generated both with a step-wise increase of
the mutation frequency and by forcing disjoint sample sets, i.e.,
sets of samples that have no genetic event in common.
Step-wise Increment of Mutation Frequency
A set of binary 20 by 20 matrices was generated starting
from a binary triangular matrix and step-wise incrementing the
mutation frequencies of genes. Figure 1A illustrates the step-wise
increment: the triangular matrix is the starting configuration;
at each step the other matrices are obtained by progressively
converting the first 0 of each row in a positive entry until the
matrix is filled with 1s. The following pseudo-code explains
how the matrices are generated starting from a binary lower
triangular matrix A(n × n) =
{
xi,j
}
. At each step the new
matrix obtained with this procedure is saved and used as input to
TO-DAG.
step: = 0
while(step < n− 1)
{
for(i in 1 : n− 1− step)
{
TABLE 2 | AUROC for the inference of TO-DAG, RESIC, and CT-CBN on
synthetic gold-standards of different size.
# Nodes # Edges TO-DAG RESIC CT-CBN
10 30 0.83 0.70 0.81
100 300 0.71 0.63 NA
1000 3000 0.85 0.69 NA
x(i,j+1−step) ←1;
Astep ← A {x } ;
save {Astep } ;
}
step← step+ 1
}
For each matrix obtained with this procedure, the graph of the
mutation events has been inferred with the four approaches.
Oncotree
Figure 1B shows that as the frequency of mutation increases the
number of events separated from the root decreases. Columns
entirely filled by 1s are not separable from the root event. In the
extreme case in which all except the last column are entirely filled
by 1s, the tree shows the root connected with the twentieth event.
CT-CBN
CT-CBN output is identical to the output of the oncotree method
(see Figure 1C). Importantly, as CT-CBN implementation only
considers mutation events that are distinct in the time domain
(separable events; Beerenwinkel et al., 2007a,b), datasets with
identical combinations of events (identical columns) need to be
pre-processed in order to collapse identical columns (events) in
to one column (event).
RESIC
The graphs inferred by RESIC do not report nodes corresponding
to events whose mutation frequency is greater than 80% (see
Figure 1D and absence of the events 1, 2, and 3). RESIC allows to
set two parameters, (i) the pairfreq (pf) that is the minimum co-
occurrence frequency of mutations to consider, and (ii) res, the
minimummarginal mutation frequency to consider. To improve
the outputs from the binary triangular matrices those parameters
FIGURE 4 | Oncotree inferred from a prostate adenocarcinomas dataset (Barbieri et al., 2012).
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need to be adjusted. Figure S9 demonstrates their effect on the
number of predicted edges.
TO-DAG
Genes that are altered in all samples lead to nodes with outgoing
edges only (i.e., null in-degree nodes) indicating independent
events. In case all but one column (here the last) are entirely
filled by 1s, the graph shows 19 independent events whose
outgoing edges point to the twentieth event (see Figure 1E). In
Figure S7 we observe how the distribution of the edge weights
changes correspondingly to the step-wise increment of mutation
frequency.
Assortativity and clustering coefficient as function ofmutation
frequency have been explored for the graphs inferred from inputs
matrices of Figure 1A and then compared with the one on
a random binary matrix of uncorrelated events of same size
(20 samples × 20 mutations). Figure S8 shows the results and
illustrates the behavior of these topological indices together with
FIGURE 5 | CT-CBN graph inferred from a prostate adenocarcinomas dataset (Barbieri et al., 2012).
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snapshots of the structure of the inferred networks taken at
intermediate mutation frequencies. Figures S8A,C show results
corresponding to mutation frequency range from 0.1 to 0.975
with an incremental step of 0.025. For each of the 36 mutation
frequencies, a subset of 20 random binary matrices has been
considered. The width of the error bars indicates the value of
the standard deviations of the mean value of assortativity and
transitivity, respectively. Figures S8B,D show the behavior of the
indices calculated on the 20 matrices obtained from the lower
triangular matrix by progressive filling of each row by 1s.
In Figures S8A,B we observe that the absolute value of
assortativity ranges from 0 to 0.5 and decreases as the density
of the connections decreases, i.e., as the number of independent
nodes increases. By definition, assortativity is not quantifiable in
the limit case in which N–1 nodes are independent (where N
is the total number of nodes). Negative values of assortativity
indicate the tendency of the nodes to preferentially connect with
nodes of significant different degree.
Figure S8C on 20 by 20 input matrix confirms the results we
showed in Figure S5A for the case of a 100 by 60 input matrix,
and shows a low clustering coefficient at the extreme values of
mutation frequency 0.1 and 0.975. For low average mutation
frequency, as well as for very high average mutation frequency a
small number of edges is inferred, as in the both case the method
cannot determine the causal interdependencies between rare
events or on high frequency and almost equi-probable events.
Finally, Figure S8D shows the decrement of the transitivity also
in the case of a step-wise increment of mutation frequency of the
lower triangular matrix.
Disjoint Datasets
Often real human tumor datasets include tumor sub-types or
sub-classes (e.g., phenotypes, grades, stages) that might barely
share any common genomic event. To mimic such a situation,
we created a disjoint sample set (see Figure 2). Samples from
S1 to S10 harbor genomic events only from E1 to E10 where
samples from S11 to S20 only in events from E11 to E20. For each
group of samples we chose a lower triangular matrix to facilitate
the interpretation of the corresponding tree/network. The null
intersection of the sets of events is reflected in the oncotree
structure (two independent branches depart from the root), as
well as in the RESIC and TO-DAG graphs that inferred disjoint
sub-networks each one including the set of events defined in the
disjoint sets of samples. CT-CBN fails to correctly recognizing
such structure; E1 and E11, that are independent by the current
experimental design, are both pointing to E19 that is a “collector
node” for three sets of events: (2, 3, 4, 5, 7, 8), (20, 10, 9), and (12,
13, 14, 15, 16 17, 18). Moreover, events 15, 16, 17, and 18 (and also
the set of events 12, 13, 16, 17) are connected in a loop so that it
is not possible to establish a temporal order for these events.
Common Genetic Events in Separate Phenotypes
If an event, say for example E10, is present in both samples sets,
the corresponding node in the graph structure is expected to be
an independent node connected to nodes relevant to both sample
sets. Figure 3 exemplifies this experiment. TO-DAG identifies
E10 as a hub node without incoming edges and connecting
the two sub-networks related to events occurring in the two
corresponding samples sets. The oncotree approach returns a
structure where E10 is represented as an independent leaf directly
originating from the root.
RESIC tested on a similar case study, where in the inputmatrix
the E10 has been defined positive only in some samples (events
positively defined in all the samples are removed from the graph
as RESIC considered them as wild-type) does not include the
event and returns two disjoint sub-networks.
FIGURE 6 | TO-DAG model inferred from a prostate adenocarcinomas dataset (Barbieri et al., 2012). Green, orange, and red indicate fast (△t < 5),
medium-speed (5 ≤ △t < 20) and slow (△t ≥ 20) transitions. Waiting times are measured in arbitrary units (a. u.).
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Generation of in silico Benchmarks and Evaluation of
Performances
Next we turned to a more general assessment of the performance
of TO-DAG and the other three selected methods in terms of
accuracy of prediction on synthetic graphs with more complex
topological structure. We utilized a procedure for in silico
benchmark generation and performance profiling of graph
inference based on the generation of gold-standard accessible
pointed graph (APG) directed acyclic graphs and synthetic data
(Johnsonbaugh and Kalin, 1991). An APG is a directed graph
with a distinguished vertex (the “root”) such that every other
vertex is reachable from it. That is, for every vertex in the graph,
there is at least one path in the directed graph from the root to
that vertex. We chose an APG as gold-standard topology, as it is
a good compromise between the complexity of a realistic network
of genetic events and the mathematical and computational
complexity of the set of equations and constraints needed
to generate corresponding binary matrix input to TO-DAG.
Keeping this system of equations and constraints as simple
as possible allows for a better control of the generation of
indirect “relationship” between events and their strengths. It is
very hard not to introduce indirect effects between nodes using
equation-based modeling to describe network interactions. This
TABLE 3 | Size of the input dataset provided in Baca et al. (2013).
# Samples # Genes # Edges
Gains 40 941 8338
Losses 48 948 7391
Point Mutions 48 961 6922
BP Rearrangments 54 3331 318.263
FIGURE 7 | High weight (equal or above 0.8) TO-DAG model from the
prostate adenocarcinomas dataset (Barbieri et al., 2012). Green, orange,
and red edges indicate fast, medium-speed, and slow transitions. Waiting
times are measured in arbitrary units (a. u.). We refer the reader to the
GraphML file graph_figure_7.graphml in Supplementary Data to visualize this
network and to zoom in its details.
problem is often overcome by introducing noise in the equation
of a complex set of constraints on the mathematical relations
among the nodes. If the topology of the gold-standard is very
complex, the definition of this effect and the control of their
impact on the graph inference performance become complex
as well.
The procedure for the generation of a gold-standard APG is as
follows.
1. Given the number of nodes n and of edges m, generate an
unweighted random APG with n nodes and m edges. We used
the C++ software package developed by Johnsonbaugh and
Kalin (1991) to generate such sort of graph.
2. For each path starting from the root, assign a value to the
joint probability of the events represented by the nodes in the
path, i.e., for each path Pk, connecting nk nodes {vi}k where
i=1, 2, . . . , nk and k is the number of paths in the graph, define
an arbitrary value of Prob (∩vi)k
3. For each pair of nodes connected by an edge, define the
constraints on the conditional probabilities of each node given
its direct predecessor to model the directions defined in the
topology.
4. Solve the sets of constrained equations to calculate the
probabilities of the single events.
5. Generate the binary co-occurrence table with events/nodes on
the column and samples on the rows, where the mutation
frequency of each event is defined by the probability of the
event calculated in step 4.
In Supplementary Material we illustrate this procedure on a
small graph of 8 nodes. The performances of TO-DAG, CT-CBN
and RESIC on synthetic APG gold-standards of increasing size
and complexity have been evaluated in terms of Area Under
the Receiver Operating Characteristic (AUROC). See Table 2.
TO-DAG outperforms RESIC performances on networks of
large size.
TABLE 4 | Percentage of slow, medium, and fast transitions in the network
of Figure 6; PM, Point mutations; L, Losses; G, Gains; BP, Break-Point
rearrangements.
Total nr. of Edges % of Fast % of Medium % of Slow
PM↔ PM 1567 53 44 3
PM→ L 1171 54 43 3
L→ PM
PM→ G 262 54 41 5
G→ PM
L↔ L 135 58 39 3
L→ G 79 2 49 49
G→ L
BP→ PM 158 44 52 4
PM→ BP
BP→ L 0 0 0 0
L→ BP
BP→ G 0 0 0 0
G→ BP
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Experiments on Genetic Mutations from Human
Tumor Datasets
We selected two tumor types with high worldwide incidence,
prostate cancer and melanoma, for which somatic genetic
events datasets are available from whole genome and/or whole
exome sequencing experiments of human tissues (Barbieri
et al., 2012; Baca et al., 2013). Whenever the size of
TABLE 5 | Percentage of slow, medium, and fast transitions in the network
of Figure 7.
Total nr. of Edges % of Fast % of Medium % of Slow
BP↔ BP 318.263 1 1 98
G↔ G 8338 84 15 1
L↔ L 7391 64 31 5
PM↔ PM 6922 61 35 4
PM, Point mutations; L, Losses, G, Gains; BP, Break-Point rearrangements.
the input and/or the computational charge is manageable
we also present the results obtained with CT-CBN and
Oncotree.
Prostate Cancer
Oncotree, CT-CBN, TO-DAG performances have been tested on
genetic data from a total of 74 patients. First, we considered
a restricted set of 25 point mutations from the Barbieri study
(Barbieri et al., 2012) plus the recurrent fusion event involving
the ERG oncogene (Perner et al., 2007), an early event in
prostate carcinogenesis enriched in young patients (Schaefer
et al., 2013; Weischenfeldt et al., 2013). Figures 4–6 show the
tree/graph structures inferred by Oncotree, CT-CBN and TO-
DAG, respectively. As expected, all the approaches predicted
that ERG fusion event is independent from any other event, but
predicted different sets of ERG dependent events. For instance,
CT-CBN output reports linear chains for events for which
the algorithm did not infer a temporal order; RESIC predicts
TABLE 6 | In- and out- degrees of the hub nodes (i.e., nodes with Kleinberg’s centrality greater than 0.8) of the network of genetic events in prostate
cancer showed in Figure 7 for different values of the threshold on the edge weight.
Cutoff CDKN1B EPHA7 PTEN APC TP53 MLL2 ATM NCOR1 ZNF595
In Out In Out In Out In Out In Out In Out In Out In Out In Out
>> 0.8 0 27 0 29 0 43 0 25 0 30 0 15 0 7 0 15 0 34
0.7 0 872 0 756 16 1076 0 658 0 830 0 367 0 179 0 265 11 822
0.6 0 900 0 781 16 1107 0 662 0 858 0 381 0 181 0 282 11 830
0.5 0 901 7 794 16 1114 0 670 0 875 0 394 0 182 0 322 11 830
<< 0.2 0 951 7 815 16 1191 0 677 0 911 0 433 2 187 0 344 11 885
For non-hub nodes, the average ration between in- and out-degree is 0.75.
FIGURE 8 | Ratios between in- and out-degrees of prostate cancer genes (i.e., network nodes from Figure 7). Genes with out-degrees equal to zero are not
included. Values on top of each bar indicate the total node degree. For a comparison with the melanoma analysis, see in the text.
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FIGURE 9 | TO-DAG model graph inferred from a dataset including a
variety of genomic aberrations, namely copy number gains and losses,
rearrangements, and point mutations (Baca et al., 2013). This network
shows edges whose weight is greater or equal than 0.4. Only names of the
nodes with hub score above the average are reported. As a consequence, it
presents more edges than the network in Figure 7. Green, orange, and red
edges indicate fast, medium-speed, and slow transitions. The majority of
medium-low scoring hubs are connected through more than one node. The
probability of this interconnection is slightly lower than the average. Waiting
times are measured in arbitrary units (a. u.). We refer the reader to the
GraphML file graph_figure_8.graphml in the Supplementary Data to visualize
this network and to zoom in its details.
no inter-dependencies among the point mutations; where TO-
DAG output resembles the expected order of selected events
such as the dependency of PTEN from TP53 consistent with
the PTEN mutation being a late event during progression
(Barbieri et al., 2012; Prandi et al., 2014). TO-DAG also
inferred the relative velocity of the transitions distinguishing
among slow, medium-speed, and fast transitions as per the
waiting times (red, orange, and green edges, respectively;
Figure 6).
Next, we considered a larger dataset including a variety of
genomic aberrations, namely copy number gains and losses,
rearrangements, and point mutations (Baca et al., 2013). This
set was analyzed with TO-DAG and with Oncotree. Given
the complexity of the resulting networks, the Oncotree ones
are presented in Supplementary Material. TO-DAG results are
summarized in Table 3 that lists the number of samples, genes
and predicted edges and in Figure 7 that illustrates a sub-
network with edges weight greater than 0.8 and collapsed
aberration types on a node/gene basis. Full information is
retained in the GraphML format files in the Supplementary
Data with nodes labels containing aberration suffixes (PM, BP,
LOSS, GAINS). To gain an overall picture of the transitions,
we calculated the percentage of slow, medium, and fast
transitions in each network for any combination of source
and target nodes labeled as PM, Point Mutation; L, Loss; G,
Gain; and BP, Break-point structural rearrangements, as in
Tables 4, 5. Of interest the small percentage of inferred slow
transitions are between rearrangements (BP-BP) compatible with
subsequent coordinated event sets that we had previously named
chromoplexy (Baca et al., 2013) as a mechanism of punctuated
evolution.
Finally, Table 6 reports the in- and out-degree of the
hub nodes of the network, defined as nodes with Kleinberg’s
centrality greater than 0.8 for different values of edge weight
threshold. Interestingly, the analysis highlights key tumor
suppressor genes, both gatekeepers and caretakers (Kinzler and
Vogelstein, 1997) such as TP53, PTEN, and CDKN1B, as having
the smallest in- over out-degree ratios or, in other words,
as genes that when mutated behave like mutation firework
initiators (Figure 8). In the Supplementary Material, we provide
both in GraphML and tab delimited three subgraphs of the
whole network from Figure 7 (available graph_figure_7.graphml,
Supplementary Data) only including “slow” transition among
nodes, “medium-speed” transition among nodes, or “fast”
transition among nodes.
The whole TO-DAG network (including all edges with
probability greater than the mean value 0.4) is shown in Figure 9
(graph_figure_9.graphml, Supplementary Data).
Melanoma
The genomic landscape of melanoma is characterized by a
large amount of point mutations. Recent work from Berger
et al. (2012) on 25 metastatic melanomas identified key genes
that are significantly mutated including BRAF and NRAS. TO-
DAG inferred a graph with 5139 nodes and 1129,295 edges
from all 4917 melanomas protein coding point mutations. To
assess the validity of the these measures and, indirectly, to
quantify the deviation of the TO-DAG inference from the
randomness, we focused on the set of key genes and compared
their centrality measures (degree and node strength, Table 7)
with those obtained in TO-DAG graphs inferred from random
input matrices having the same size and the same density (i.e.,
the same number of positive entries) of the real input matrix.
In Table 8 the mean values of minimum, maximum, mean,
median, first and 3rd quartiles of in- and out-degree distributions
obtained from the 100 random experiments are shown. We
found that out- degree for the genes of interest are between
the mean value of the 3rd quartile and the maximum except
for NRAS, GOLGA6L6, OR2T33, and MST1, whereas the in-
degree and node strength are between the mean minimum
and the first quartile value, except for NRAS and OR2T33.
Next, we inferred putative causality networks from a reduced
data set including only cancer genes, and compared the in-
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TABLE 7 | Mutation frequency, degree, and node strength of significantly mutated genes (Berger et al., 2012) as in TO-DAG inferred graph on melanoma
case study.
Gene Mutation frequency Out-degree In-degree Out-Strength In-Strength Out-degree/Out-Strength In-degree/In-Strength
BRAF 0.391 2830 6 2002.21 0.3704 0.7075 0.0617
NRAS 0.043 0 514 0 514 NA 1.0000
PREX2 0.478 3639 1 2762.70 0.0744 0.7592 0.0744
GOLGA6L6 0.174 952 67 624.05 6.25 0.6555 0.0933
VCX3B 0.174 1022 70 693.72 6.375 0.6788 0.0911
POTEH 0.217 1589 42 1049.83 3.56 0.6607 0.0848
OR2T33 0.087 278 159 278 44.25 1.0000 0.2783
C1orf127 0.217 1969 39 1387.33 3 0.7046 0.0769
PRG4 0.345 2628 7 1861.11 0.4219 0.7082 0.0603
MST1 0.217 1332 44 857.75 3.56 0.6440 0.0809
TABLE 8 | Average quartiles of the in-degree and out-degree distribution
the distributions have been obtained from 100 TO-DAG graphs inferred
from 100 random binary matrices of the same size and density of the real
data matrix in Berger et al. (2012).
Quartiles In-degree SD of Out-degree SD of
in-degree out-degree
Min. 0 0 0 0
1st 144.87 2.03 0 0
Median 156.54 2.1 0 0
Mean 151.08 0.13 151.08 0.13
3rd 166.5 1.75 305.22 3.23
Max. 184.83 5.58 4120.2 28.76
and out-degree of BRAF and NRAS with the distribution of
in- and out-degree of these genes obtained from 100 TO-
DAG inferences from 100 binary matrixes where the mutation
frequency of each single gene is kept constant and equal to
the real data. Results are shown in Table 9. The degrees in real
cases deviated from the mean values of the random case, that
are DBRAF
◦ut = (178.94 ± 9.21) and DNRAS
in = (15.01 ±
4.07).
All genes showed out-degrees larger than in-degrees in line
with their significant mutation frequency and the mathematical
definition of TO-DAG weights. The only exception was NRAS
that exhibited null out-degree and in-degree equal to 514. When
comparing the NRAS induced sub-graphs of order 1 with the
NRAS pathway from Pathways Commons PPI database (http://
www.pathwaycommons.org/about/; 1030 nodes and 388,000
edges) we found 20 direct interactions of NRAS present in both
graphs (Table 10) including a link from BRAF to NRAS.
The NRAS induced sub-graphs of order 2 (30 nodes and 378
edges) extracted from the whole melanoma graph is provided as
a GraphML file (NRAS_order2_subG.graphml, Supplementary
Data); Figure 10 shows the sub-graph restricted to edges with
weight greater than the mean value (equal to 0.15).
Where these large network results are exploratory in nature
and should be followed by independent validation, they provide
the first time directed networks from large human sample
mutational datasets. These analyses can highlight nodes and
bottlenecks during tumor evolution that can inform key elements
in cancer progression.
CONCLUSIONS
We presented TO-DAG, a new tool suitable to model non-
memoryless process of mutations accumulation, to handle very
large datasets and to estimate the waiting time of transitions
from the occurrence of a mutation to the occurrence of the
subsequent one. TO-DAG competes with the current DAG and
tree models, and in particular with the more complex Bayesian
models, in the accuracy of estimating the order and the waiting
time of mutation events. The theoretical model of the majority
of graphs is based on pairwise dependencies between genetic
events. Furthermore, the majority of timed graph models assume
that mutations are random events and that the process of their
accumulation is a memoryless stochastic process. Due to these
assumptions, current graphmodels are a simplistic generalization
of the tree models and allow only the specification of stochastic
process having the Markov property. Such property holds when
the conditional probability distribution of future states of the
process (conditional on both past and present state) depends
only upon the present state, not on the sequence of events that
preceded it.
TO-DAG discards the Markov property assumption and is
not limited to compute “pairwise” dependencies between genetic
events. As a consequence, the new probabilistic theory of TO-
DAG allows for the inference of pathways of causal dependencies
among genetic alterations more closely reflecting the dynamics of
the mutation accumulation process during cancer progression.
Such probabilities can be estimated directly from the data,
and the waiting times of the mutation events are estimated a
posteriori as stochastic function of their conditional probability.
In the TO-DAG inferential framework the probability of
occurrence of a mutation is not a function of the time. The
reason of such a probability model is the impossibility to measure
the exact time at which a mutation occur. The estimation of
the waiting time of mutation is carried out once the causal
dependency topology of the graph has been determined. Finally,
since no a priori assumptions about the order and the timing
of mutation accumulation process is needed and no parameters
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TABLE 9 | In- and out-degree of BRAF and NRAS genes in TO-DAG network inferred from Cancer Genes list. (A) Summary of the distributions of
in-degree (B) and out-degree (C) obtained from 100 TO-DAG networks inferred from 100 random binary matrices, where the mutation frequency of each
single gene is kept equal to the real one.
Out-degree In-degree
(A)
BRAF 213 0
NRAS 0 60
Min. 1◦ Qu Median Mean 3◦ Qu Max
(B)
BRAF 0 0 0 0 0 0
NRAS 6 12 15.5 15.91 18 26
(C)
BRAF 160.0 172.0 179.0 178.9 187.2 204
NRAS 0 0 0 0 0 0
TABLE 10 | Edges in the intersection of TO-DAG NRAS sub-graph of order
1 (514 edges and 513 nodes) and NRAS pathway as reported in Pathways
Commons (1030 nodes and 388,000 edges).
Source Target
MLLT4 NRAS
SPTA NRAS
KLB NRAS
RASA2 NRAS
PIK3C2G NRAS
CSF2RB NRAS
BRAF NRAS
ANGPT1 NRAS
KIF20B NRAS
FLNB NRAS
EPS8 NRAS
DYNC1H1 NRAS
DST NRAS
DIDO1 NRAS
CPNE3 NRAS
ANKRD11 NRAS
NF1 NRAS
MYOF NRAS
EXOC4 NRAS
CKAP5 NRAS
477 nodes/genes present in the whole network of the melanoma case study (Berger et al.,
2012) are not reported in the NRAS pathway.
other than the confidence level γ are needed as input of
the inferential procedure, the TO-DAG faithfully represent the
topological structures embedded in the input data.
A comprehensive comparison of the results obtained with
TO-DAG with approaches from the three main categories of
mutation patterns inference has been presented and discussed
in terms of five main aspects: (1) the computational complexity
and the subsequent ability to successfully deliver an output from
huge amount of data (compatible with the current state of the
art in cancer genomics), (2) the outputs from random data to
estimate the number of putative false positive as function of the
number of genetic events, number of samples, and mutation
frequency; (3) the outputs from synthetic data generated by a
step-wise increase of the mutation frequency to assess how and
the extent to which each inference model reflects the input data
structure in a graph; (4) the outputs from data in which sample
set do not share (and do share) positive occurrences of genetic
events to assess the ability of the methods to infer disjoint (joint)
graphical models corresponding to disjoint (joint) sample sets,
and (5) the assumption and approximation that each method
adopts in its theoretical framework (e.g., memoryless property,
removal or collapse in unique events of aberrations positively in
all samples).
Oncotree and TO-DAG exhibited similar good performances
across multiple comparisons (1–4), however thanks to the graph
based approach TO-DAG outperforms Oncotree whenever a
slightly complex topology is involved and requires nodes with
more than one parent and/or when parents are connected. The
former especially is crucial in cancer genomics as independent
paths can lead to the same crucial event. TO-DAG output exactly
reflects complex topological structure embedded in the synthetic
data. Indeed all the expected interactions are correctly predicted.
Oncotree, RESIC and TO-DAG infer disjoint subnetworks
corresponding to disjoint sample sets, whereas CT-CBN revealed
a strong limitation on this case study. Moreover, CT-CBN, given
the complexity of mathematical structure formalizing a Bayesian
inference model, is limited to few tens of input events and
samples and to an average/low sparseness of the data. RESIC is
very well performing with regard to aspect 2, as it has a very low
rate of false positive predictions with respect to TO-DAG and
CT-CBN.
Furthermore, TO-DAG can process huge datasets and
implements a new theoretical model in which the accumulation
of genetic events during cancer development is a probabilistic
timed non-memoryless process. In contrast with the majority of
DAG-based methods (especially the Bayesian ones), TO-DAG is
not parametric and does not require any a priori knowledge on
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FIGURE 10 | NRAS induced sub-graph of order 2 extracted from the TO-DAG model inferred from a metastatic melanoma dataset including somatic
base pair mutations in protein coding regions (Berger et al., 2012). Of the NRAS induced sub-graph of order 2 containing 30 nodes and 378 edges, only edges
with weight above the mean value (0.15) in the subgraph are shown in this figure.
the causal dependencies among genetic events; TO-DAG inferred
topologies are deduced only from the conditional probabilities
estimated from the data.
Finally, TO-DAG represents a solid alternative to sequence
based evolutionary approaches that ultimately utilize lesion
clonal state or allele frequency information to construct evolution
charts (Carter et al., 2012; Prandi et al., 2014). TO-DAG is readily
applicable to mutation or aberration data irrespectively from the
experimental platform used to generate the data.
Altogether, the formal comparison of available approaches
and the introduction of new methods able to deal with state-of-
the-art genomic datasets improves our ability to make the best
use of the current genetic information eventually resulting in the
identification of suitable drug targets relevant to tumor initiation
and progression.
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